8/3/2023

speaker
Operator

Hello and welcome to the NLITE second quarter 2023 earnings conference call. All participants are in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, you may press star, then 2. Please note, this call is being recorded. At this time, I would like to hand the call over to Joe Corso, NLEIT's Chief Financial Officer. Please go ahead.

speaker
NLITE

Thank you and good afternoon, everyone. I'm Joe Corso, NLEIT's Chief Financial Officer. With me today is Scott Keeney, NLEIT's Chairman and CEO. Today's discussion will contain forward-looking statements, including financial projections and plans for our business, some of which are beyond our control, including the risks and uncertainties described from time to time in our SEC filings. Our results may differ materially from those projected on today's call, and we undertake no obligation to update publicly any forward-looking statement except as required by law. During the call, we will be discussing certain non-GAAP financial measures. We have provided reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures in our earnings release, which can be found on the investor relations section of our website. I will now turn the call over to Scott.

speaker
Joe Corso

Thank you, Joe. In the second quarter, we delivered results that were largely in line with guidance. Revenue of $53.3 million was above the midpoint of the guidance range. Products gross margin of approximately 29% and continued operating expense control resulted in adjusted EBITDA that was also above midpoint of the guidance range. We also made significant progress in three areas critical to our strategic growth objectives. In aerospace and defense, we kicked off the Health C2 program and made excellent progress in our new defense applications. In industrial, we continue to improve our position with key customers and have seen increased traction with our process monitoring solutions. And operationally, we have continued to diversify and de-risk our manufacturing strategy. We have established automated assembly of semiconductor lasers in the US, and in addition, have begun shipping from a contract manufacturer in Thailand. I will provide a brief update on each of these three initiatives and our revenue outlook. In aerospace and defense, revenue increased 9% year over year to $24.5 million, representing 46% of total revenue. Second quarter development revenue increased 8% year over year to $13.7 million. And defense products revenue increased 9% year over year to approximately $10.8 million. As we announced in early May, we were awarded a new $86 million contract to produce a more powerful, higher performance laser related to the second phase of the Department of Defense High Energy Laser Scaling Initiative, which we refer to as LC2. In late Q2, we kicked off Hell C-2 activities and recognized initial revenue from this program, which we expect to continue for approximately two plus years. In addition, we also announced that our Hell C-1 laser was formally accepted by the government and is being prepared for integration within the U.S. Navy's high-energy laser counter-anti-ship cruise missile program. We continue to believe that our unique technology and vertical integration from chip through beam control are well suited to be scaled to increasingly higher powers. And we are proud to continue to support the US government's efforts in higher power directed energy lasers. We are excited about our current programs in directed energy and we are working on several new opportunities that we look forward to sharing in coming quarters. In non-directed energy defense, we generated higher revenue from existing long-running programs, and we made significant progress on a number of new programs. We expect to continue to support our long-running programs well into the future, and we believe our new programs remain on track to transition to production sometime in 2024. Turning to the industrial end market, industrial revenue in the second quarter declined 24% year-over-year to $16.6 million, representing 31% of total revenue. In cutting, we continue to leverage our all-fiber programmable technology to deliver innovative, increasingly higher-powered lasers to our customers. Revenue from cutting customers was relatively flat year over year and in line with our expectations when we provided second quarter guidance. While the overall demand environment remained muted, we did gain share with one of our top customers and again increased the overall number of 15-kilowatt and 20-kilowatt lasers sold. In welding, we've continued to expand our process monitoring sales in the European, North America, and Chinese EV battery market. Our suite of process monitoring solutions and battery monitoring experience opened up new opportunities for both process monitoring and laser sales in the EV market. Part of the strategic rationale for our acquisition of Plasma last year was to capitalize on cross-selling opportunities between Enlight Lasers and Plasma process monitoring solutions. While revenue from welding customers is a relatively small part of our overall industrial business today, during the second quarter we had several new customer wins and significantly increased our engagement with potential customers. Additive continues to offer significant long-term growth opportunities for us. Our Corona single-mode AFX fiber laser has been widely demonstrated to increase build rates by a factor of 2 to 8x, which substantially reduces part cost. In addition, our laser simultaneously maintains excellent material quality, increases the process window, and reduces deleterious effects such as soot, spatter, and porosity that affect laser powder bed fusion tools based on legacy fiber lasers. Our lasers have enabled tools by leading integrators, including DMG MORI, Velo3D, AMCM, Econody3D, and several others that we are not able to specifically call out. Q2 additive revenue was slightly above what we had expected when we provided guidance for the quarter, but was down year over year as one of our customers is still in the process of integrating lasers they had purchased last year. In microfabrication, revenue in the second quarter of 2023 declined 26% year over year to $12.2 million, which represented approximately 23% of total revenue. We continue to believe that we are a leader in the market, but global demand remains soft as customers continue to digest existing inventory. While we saw some signs of recovery during the beginning of the quarter, revenue did not materialize in the way that we had hoped, particularly in China. We remain actively engaged with our key existing customers, and we expect that its global demand environment becomes more constructive. Our semiconductor laser business will grow off the current levels. Turning to operations, we again made excellent progress in automation during the quarter. By the end of the second quarter, we achieved key milestones in the utilization of our equipment and manufacturing throughput. We also continue to mature our overall automation process flow, which over time will result in better yields and additional potential output. We are also pleased to announce that we signed a manufacturing agreement with FabriNet, a world-class contract manufacturer provider with a strong footprint in Thailand. FabriNet has a long history of delivering outsourced manufacturing services to the photonics industry. Our partnership with FabriNet provides additional high-quality, low-cost semiconductor laser assembly for our commercial business and enables increased flexibility for us to scale with demand, effectively making a portion of our manufacturing capacity variable. Most importantly, however, is that working with FabriNet enables us to dedicate a greater proportion of our U.S.-based manufacturing capacity to our defense business, which is expected to ramp significantly in the coming quarters. Our initial qualifications have gone well, and we expect to begin shipping products with FabriNet assembled lasers in the coming weeks. Now we'll turn to our current revenue outlook for the third quarter and beyond. We currently expect third quarter revenue to be in the range of $47 to $51 million. At the time of our last earnings call in May, we had been anticipating a third quarter that was approximately $5 to $10 million higher than the midpoint of our Q3 guidance. While we remain highly optimistic about both our near and long-term prospects, I'd like to describe the two primary drivers that are impacting our current Q3 outlook. First, the initial ramp of Health C2 is going a bit slower than we anticipated due to the availability of materials affecting the amount of work that we've been able to perform on the project. This slower than anticipated ramp accounts for approximately half of the delta. There have been no changes to our longer term schedule, and we expect revenue to begin to ramp more significantly over the next few quarters. The other half of the delta was driven by lower overall demand, particularly in microfabrication. As we look towards 2024, however, our customer demand pipeline and revenue visibility have actually strengthened quite a bit. So although our revenue ramp in Q3 is a bit slower than what we had expected a quarter ago, new defense program wins and continued execution in commercial business will begin to come to fruition in 2024, resulting in even stronger growth than we had expected entering this year. In summary, we've made excellent progress over the last several quarters despite the fact that our top-line revenue is currently ramping more slowly than our expectations. Our opportunities in defense, in both directed energy and our core business, have continued to expand. We also believe that our core technology, particularly our programmable lasers and process monitoring capabilities, coupled with strong secular trends in additive and welding, are driving strong expected growth in 2024 and beyond. I will now turn the call over to Joe.

speaker
NLITE

Thank you, Scott. Enlite generated revenue and adjusted EBITDA above the midpoint of our guidance. Growth and gross margin improvement is a core focus of the Enlite leadership team. While scale and mix are the primary drivers of gross margin, the combination of higher output and efficiency of our U.S. automation, coupled with the outsourced assembly of some of our semiconductor lasers to FabriNet, offers further room for gross margin improvement. In a period of continued macroeconomic softness, we are carefully monitoring operating expenses and capital expenditures so that higher revenue levels, we are able to drive better levels of profitability. Total revenue for the second quarter of 2023 was $53.3 million above the midpoint of guidance compared to $60.8 million for the second quarter of 2022. Products revenue was $39.6 million compared to $48.2 million for the second quarter of 2022. Revenue decreased year over year in both the industrial and microfabrication markets, but increased year over year in aerospace and defense. Gross margin was 23% compared to 25% for the second quarter of 2022. Products gross margin was 29% compared to 30% for the comparable period in 2022. Products gross margin in the second quarter was negatively impacted by negative manufacturing variances and lower production volumes, but positively impacted by favorable product mix and decreased overall manufacturing costs. Non-GAAP operating expenses were $16.6 million, a decrease of $2.7 million compared to $19.3 million for the second quarter of 2022. The decrease in operating expenses was driven by a decline in employee compensation costs, primarily due to lower headcount, decreases in R&D project spending, and higher administrative costs that were allocated to development projects. On a GAAP basis, operating expenses were $23.8 million, a decrease of $1.9 million compared to $25.7 million for the second quarter of 2022. Net loss on a non-GAAP basis was $900,000 or $0.02 per diluted share, compared with a net loss of $3.3 million or $0.07 per diluted share for the second quarter of 2022. Net loss on a GAAP basis was $8.8 million or $0.19 per share, compared to a net loss of $10.3 million or $0.23 per share for the second quarter of 2022. Adjusted EBITDA was a negative $150,000 above the midpoint of guidance compared to positive $200,000 for the second quarter of 2022. Cash used in operations was $4.1 million compared to cash used for operations of $4.8 million for the second quarter of 2022. Included in cash flow from operations was an $8.4 million increase in accounts receivable due primarily to the timing of billings and collections during the quarter. Capital expenditures were $1 million compared to $7.9 million for the second quarter of 2022. While capital expenditures will increase in subsequent quarters, overall CapEx in 2023 will be down significantly year over year. We also used approximately $3 million of cash on tax payments related to stock award issuance during the quarter, which we do not expect to repeat at this level in subsequent quarters. Turning to the balance sheet. Our balance sheet remains strong as we ended the second quarter of 2023 with total cash, cash equivalents, restricted cash, and investments of $102 million and no debt. Our DSO for the quarter was 70 days and inventory at the end of the second quarter was 64.9 million, representing 144 days of inventory. Turning to guidance. Based on the information available today, we expect revenue for the third quarter of 2023 to be in the range of $47 million to $51 million. The midpoint of $49 million includes approximately $36 million of product revenue and approximately $13 million of development As Scott discussed earlier, at the time of our last earnings call, we were expecting our third quarter to be approximately $5 to $10 million higher than the midpoint of today's guidance range. About half of the difference is simply related to the availability of materials limiting how quickly we could ramp on our Health C2 program, while the other half is really driven by a slower recovery in macroeconomic demand for our microfabrication business. We've made excellent progress in Health C2 during the third quarter, but it's still difficult to predict when the macroeconomic environment will really begin to drive higher demand in microfabrication. Turning to gross margin. Third quarter 2023 products gross margin is expected to be in the range of 27% to 31%, and development gross margin to be approximately 7%, resulting in an overall gross margin range of 22% to 25%. Finally, we expect adjusted EBITDA for the third quarter of 2023 to be in the range of approximately negative $3 million to break even. As a reminder, over the last several quarters, we have significantly streamlined our cost structure and continue to expect to return to positive adjusted EBITDA at a quarterly revenue run rate in the $55 to $60 million range. With that, I will turn the call over to the operator for questions.

speaker
Operator

Thank you. We will now begin the question and answer session. To ask a question, you may press star, then 1 on your telephone keypad. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw from the question queue, please press star, then 2. At this time, we will pause momentarily to assemble our roster. The first question today comes from Ruben Roy with Stiefel Nicholas. Please go ahead.

speaker
Ruben Roy

Thank you. Hi, Scott and Joe. I wanted to start, Scott, with a question on guidance and sort of how to think about the out-quarter. In the earnings release, you had a little statement talking about being optimistic about strong growth returning in subsequent quarters and in 2024. You talked a lot about 2024, but as we think about Q4, should we expect some of the materials that are necessary to keep healthy going to become available and is that going to help you get back to, you know, sort of revenue growth in Q4 or, you know, any signs of, you know, sort of a bottoming process in microfeb? Any detail around that would be helpful.

speaker
Joe Corso

Yeah, absolutely, Ruben. Thanks for the question. You know, as I noted, you know, the delta I described was due to timing for Halsey and then sort of the macro effects. So as we look out in time, certainly the Halsey program, you know, contracts in place. And so we fully expect to be ramping there as material and other resources are available. Now, with respect to the macro environment, that's harder to predict what's going on in the macro environment. But in addition, we have other opportunities that we're making good progress in, notably both in defense and in the industrial markets. So that's the reason for our optimism about the core bets that we've made for growth and you know, the relatively near-term, you know, outlook for those to come to fruition.

speaker
Ruben Roy

Okay. Thank you, Scott. I guess a follow-up to that would be around the Fabernet contract. Just kind of wondering about the timing about the contract given, you know, kind of where we are in the macro. And I guess longer term, if you have some, you know, detailed comments to make about how you're thinking about NICs, internal to outsourced, and if – you know, we should think about any longer-term margin impacts on, you know, commercial laser products as that makes shifts potentially, you know, over to contract manufacturing.

speaker
Joe Corso

Yeah, good. Let me take the first part of the question, and I'll hand it over to Joe on the margin impact. On the first part of the question in terms of timing, you know, I think the, you know, we're really pleased with the progress that the team has made here, and we will start shipping from Fabrinet this quarter. And we see this as part of our overall de-risking strategy. And we see this as an important part of our mix going forward. In particular, making sure that we have the capacity in the U.S. for ramping defense programs while having a balanced portfolio of capabilities to continue to serve the commercial market. So, you know, pleased with the progress there and with the, you know, the portfolio we have in place now to address both the industrial and the defense markets. And then with respect to the margin implications, let me hand it to Joe to answer that question directly.

speaker
NLITE

Yeah, good question, Ruben. So from a margin perspective, we expect that margin to be neutral or potentially positive. If you think of what a relationship with a Fabrinet or a contract manufacturer does, it effectively enables us to variabilize some portion of our manufacturing and match demand with manufacturing output. And so hopefully be able to sort of avoid some of those, you know, peaks and valleys. So over time, we think, you know, at worst, this is margin neutral. At best, it gives us the opportunity to, you know, continue on our path to 40% product gross margins or better.

speaker
Ruben Roy

That's great. Thanks for that detail, Joe. If I can sneak one last one in. It was great to hear about the plasma traction program. Got it. I think you mentioned that you're seeing, you know, sort of attached laser sales with plasma, but just wondering if that's what you meant in terms of the new winds, or is it a combination of both, you know, kind of your vertically integrated systems plus monitoring winds, you know, with non-enlight laser that are lasers that are out there, you know, in EV installations?

speaker
Joe Corso

Yeah, very good question. It is both. We do think that, you know, having the process monitoring from Plasma gives us the opportunity for, you know, new design wins that we might not otherwise have. But then it also gives this cross selling for customers. You know, our current lasers and notably new lasers that we are developing for that market and further insights into, you know, the roadmap for what's going on there. So, yeah, that was something we wanted to note that we're making progress. There was about a year ago that we acquired Plasma and we do think that. Process monitoring is a very important part of many of the applications that we serve, and that by integrating that with our lasers, it provides a complete and further optimized solution, and in particular here in the EV battery market, in a market that is very dynamic and growing. Right. Excellent.

speaker
Ruben Roy

That's all I have. Thank you. Thanks, Ruben.

speaker
Operator

The next question comes from Jim Rashudi with Needham & Company. Please go ahead.

speaker
Jim Rashudi

Hi, good afternoon. I wanted to go back to the Fabrinet announcement, and maybe you could just walk us through the timeline. Obviously, you've known these guys for a while. They're pretty well known in terms of this industry. But the actual decision to go this route, it sounds like this was – being driven by the momentum that you've seen in the defense business. But maybe if you could just help us understand, you know, the whys and timing around it.

speaker
Joe Corso

Yeah, Jim, you know, certainly I've known Fabrinet for a long time and I've always been impressed. We did look at multiple CMs here and, you know, very pleased with the capabilities at Fabrinet. They've done a very good job serving the industry for many years now. And in terms of the decision here, it's about diversifying and mitigating manufacturing risk further. As we've talked about, we're transitioning manufacturing from our current manufacturing in China. We've got our automation up and running in the US. But the contract manufacturing piece of this serves particular products and particular markets in an optimized way. So it's about having that portfolio that both diversifies risk, and as Joe mentioned, to variabilize as part of our manufacturing capacity. So those are the overarching reasons. We've been working on this for some time. I've been engaged with them for many years now. But we're pleased to announce that we are shipping from Fabrinet. And we're pleased with this transition that we've talked about for some time.

speaker
Jim Rashudi

Okay, I think I understand the optimism that you have around the defense business as you think about 24, but we're still a ways off from early 24 to have some line of sight that gives you optimism on the industrial side. So it sounds like you're working with some newer customers. Can you help us understand the types of applications and the confidence that you have that that could contribute to revenues early next year or presumably early next year.

speaker
Joe Corso

Yeah, exactly, Jim. Yeah, so as you know, in the defense market, obviously we've got longer-term visibility in the industrial markets. You know, in many cases it's harder to see out. However, when we're talking about design wins, that's where we do have the visibility advantage. And notably, in both additive and, as I just mentioned, in welding, that's where there's a longer-term design-in process, and we're seeing good progress. I mentioned the process monitoring a minute ago, but in addition, you know, our Corona programmable beam technology continues to be adopted across all of our markets. But I would highlight again, in additive manufacturing, we do think that the Krona AFX technology has a distinct advantage. And we look forward to making announcements at the appropriate time and coming trade shows and other venues. for these design wins and new product launches. You know, there's upcoming trade shows in the fall in the industrial markets, both in the battery market and in the additive market. But those are the key drivers for us that give us the optimism for new design wins that are new products with current customers and new customers that give us that optimism.

speaker
Jim Rashudi

So, Scott, do you have customers in the EV battery manufacturing market that you're adding other than the customers that you're working with where you've had traction with the process monitoring solutions? I'm talking specifically about the lasers.

speaker
Joe Corso

Correct. Yes. These are these are new customers. Some existing customers were expanding and some new customers also. You know, again, that market is a rapidly growing one. It's one that is evolving fairly rapidly. And we've always had, you know, good relationships, but we're expanding those. And we've got good presence not only in the U.S., Europe, South Korea and China.

speaker
Jim Rashudi

So if you look out to 24, you think that this part of the industrial business, does it have the potential to be meaningful in your overall industrial revenue stream?

speaker
Joe Corso

Well, I think from a revenue standpoint, you know, I would highlight defense and probably additive on the incremental ads more. But in terms of, you know, the progress we're making, certainly we hope to, you know, provide more background there in, you know, battery welding also.

speaker
Jim Rashudi

Okay. Thanks a lot.

speaker
Joe Corso

Thanks, Jim.

speaker
Operator

The next question comes from Greg Palm with Craig Hallam Capital Group. Please go ahead.

speaker
Greg Palm

Hi, this is Danny Egerich on for Greg today. Thanks for taking the questions, guys. I think first maybe just digging into the Q3 guide a little bit more and some of the assumptions behind that. I guess from a geographic perspective, what you're seeing out there, it seems like North America held up relatively well, and maybe there was some weakness in Europe. and then end markets. I appreciate the color on microfab, but expecting solid growth in A and D still, and then maybe industrial falls somewhere in between there.

speaker
NLITE

Yeah, thanks, Danny. I think the way that I would characterize the guide is, you know, we have a little bit more visibility, obviously, in the defense business. So we have a better perspective on what we can what we can do in defense, as we talked about in Q2. Part of that is really going to be, you know, sort of some of this project timing, both from a you know, labor and labor and material perspective. But and we continue to sort of see macroeconomic challenges in the third. Sorry, macroeconomic weakness in both the industrial and micro markets. So it's been really difficult, really difficult to predict that. how the customers are, you know, what their take rate, you know, is really going to be. And that's globally, that's both in China, you know, and the rest of the world. So I almost would categorize, you know, the third quarter, you know, a couple of million dollars either, you know, either way is sort of, you know, hopefully kind of bumping along the bottom. But, you know, as Scott said earlier, right, we've got what we think the right design wins in place with the right customers, you know, coupled with some defense wins that, you know, we do think that that is going to grow. But, you know, in the third quarter, it's a lot of the same that we saw in the second quarter, quite frankly.

speaker
Greg Palm

Okay. Makes sense. And then maybe one on gross margin in Q2, just looking at kind of the sequential step down. Yeah. off similar revenues to Q1, and it sounds like mix wasn't necessarily a factor. Can you just go through what was kind of the drivers behind that sequential step down?

speaker
NLITE

Yeah, great. It was limited sort of exclusively to manufacturing quarter over quarter, right? I mean, as we are changing our overall manufacturing processes, right, we still, you know, don't have perfect, you visibility or the ability to predict what things like, you know, scrap and yield are always going to be quarter over quarter. So that was one of the pieces, you know, the other pieces we talked about Fabrinet, there were some, you know, one time, you know, charges that we needed to take again, not, not huge, but, you know, 100, 150 basis points can explain, you know, half of the sequential step down quarter to quarter to quarter. At the same time, you know, if you look at what we are doing on a normalized basis and our ability to leverage our overhead and manufacturing, that continues to trend in the right direction. I know your question was relative to the prior quarter, but as we're looking at the business and we're looking at progress on the manufacturing front, if you were to kind of go back a year ago, and look at what our product revenue was, and that was $9 or $10 million higher than it was in the second quarter, and the product's gross margin was about the same. So that gives us the optimism that we're really starting to dial in the manufacturing and the expenses around it such that as revenue grows, we're going to be able to put a lot more through to the bottom line from both an adjusted EBITDA and a cash flow basis.

speaker
Greg Palm

Okay, got it. Maybe one last one on healthy. Good to hear that started in the quarter. Can you just remind us of how we should think about the timing of that revenue ramp? Is it linear? Is it going to build throughout 2024? Or how should we think about that?

speaker
NLITE

Yeah, it's definitely not going to be linear. I don't think we've said anything, nor has anything been released publicly specifically about the period of performance on that contract. But, you know, it's a multi-year contract. multi-year contract, I think directionally it will, you know, move up, particularly as we start to, you know, allocate more resources and more material and hit milestones of that program. But, you know, hard to sort of say, you know, we can draw a line from, you know, zero, you know, straight up with the same slope to 86 million. But it'll increase over the, you know, coming periods.

speaker
Greg Palm

All right, thanks. I'll leave it there. Sure. Thank you, Dan.

speaker
Operator

Seeing no further questions, this concludes the question and answer session. I would now like to pass the call back over to Joe Corso for closing remarks.

speaker
NLITE

Yeah, thanks, everybody, for joining today and for the interest in NLIGHT. We look forward to talking to many of you during the quarter. Have a good afternoon.

speaker
Operator

The conference is now concluded. Thank you for your participation. You may now disconnect.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-